A Study of LAD191 in Adults With Hidradenitis Suppurativa

Summary

The main purpose of this study is to assess the efficacy of multiple dosing regimens of LAD191 compared to placebo in participants with moderate-to-severe Hidradenitis Suppurativa (HS) and to access the safety, tolerability, pharmacokinetic and immunogenicity in participants with moderate-to-severe HS.

Timeline

Start

2025-11-05

Primary completion

2027-05-25

Completion

2027-11-25

Drugs

Indications